NetworkNewsBreaks – Kaival Brands Innovations Gr
Post# of 402
(Total Views: 347)
Posted On: 11/11/2020 3:42:33 PM
NetworkNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Leveraging Patented Science to Create Unique Products
Kaival Brands (OTCQB: KAVL), a company focused on developing products into mature, dominant brands, has turned its attention to a new space through acquisition of a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products. The company’s newly created and wholly owned subsidiary — Kaival Labs — will own the patent and develop associated products. “The science behind these patents has discovered that within the nicotine molecule, the S-isomers control the addictive properties, whereas the R-isomers control the beneficial qualities of the nicotine that a user enjoys,” said Kaival Brands CEO Niraj Patel. “The exclusivity is that the patents allow us to control the specific ratios of each isomer in the final synthetic nicotine molecule we produce for cessation products. We can now create completely unique products for smoking cessation and nicotine addiction therapy that remain effective and satisfying for the user but are free from nicotine’s addictive traits.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Kaival Brands (OTCQB: KAVL), a company focused on developing products into mature, dominant brands, has turned its attention to a new space through acquisition of a patent covering the creation of all synthetic nicotine smoking cessation and synthetic nicotine addiction therapy products. The company’s newly created and wholly owned subsidiary — Kaival Labs — will own the patent and develop associated products. “The science behind these patents has discovered that within the nicotine molecule, the S-isomers control the addictive properties, whereas the R-isomers control the beneficial qualities of the nicotine that a user enjoys,” said Kaival Brands CEO Niraj Patel. “The exclusivity is that the patents allow us to control the specific ratios of each isomer in the final synthetic nicotine molecule we produce for cessation products. We can now create completely unique products for smoking cessation and nicotine addiction therapy that remain effective and satisfying for the user but are free from nicotine’s addictive traits.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Kaival Brands Innovations Group, Inc. (KAVL) Stock Research Links
Scroll down for more posts ▼